SCHEMBL707184

SCHEMBL707184

CNCCC(C)(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10245374 0.82
SCHEMBL13174433 0.80 ALDH1A1 (0.45)
SCHEMBL20221182 0.78 CNR1 (0.35)
SCHEMBL3280773 0.78
SCHEMBL18671042 0.77
SCHEMBL29265026 0.77
SCHEMBL15944115 0.77 ALDH1A1 (0.36)
SCHEMBL22435188 0.75
Water SCHEMBL20657274 0.75
SCHEMBL18462779 0.73 PRMT3 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113135922-A Azacycloheptane [4,3,2-cd ] isoindol-2-one derivatives and application thereof 中国药科大学 2021-07-20 CN claimed
CN-102549133-A Detergent composition PROCTER & GAMBLE 2012-07-04 CN claimed
EP-2295530-B1 Detergent composition PROCTER & GAMBLE (US) 2011-11-23 EP claimed
WO-2011031702-A1 DETERGENT COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2011-03-17 WO claimed
US-20110065626-A1 DETERGENT COMPOSITION THE PROCTER & GAMBLE COMPANY 2011-03-17 US claimed
EP-2295530-A1 Detergent composition The Procter & Gamble Company (US) 2011-03-16 EP claimed
CN-122055401-A Soil release polyesters for use in detergent compositions 科莱恩国际有限公司 2026-05-15 CN disclosed
EP-4727939-A1 5-(CINNOLIN-6-YL)THIAZOLE COMPOUNDS FOR TREATING NEUROLOGICAL DISORDERS Prothena Biosciences Limited (IE) 2026-04-22 EP disclosed
US-12528826-B2 [1,4]oxazepino[2,3-c]quinolinone derivatives as BCL6 inhibitors CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2026-01-20 US disclosed
US-20260000076-A1 ANTIMICROBIAL COMBINATIONS CLARIANT INT LTD (CH) 2026-01-01 US disclosed
EP-4637352-A2 ANTIMICROBIAL COMBINATIONS CLARIANT INTERNATIONAL LTD (CH) 2025-10-29 EP disclosed
EP-4634265-A1 POLYESTERS CLARIANT INTERNATIONAL LTD (CH) 2025-10-22 EP disclosed
WO-2025132402-A1 PROCESS FOR THE PREPARATION OF POLYESTERS USING TEREPHTHALIC ACID CLARIANT INTERNATIONAL LTD (CH) 2025-06-26 WO disclosed
EP-2295530-A1 Detergent composition The Procter & Gamble Company (US) 2011-03-16 EP disclosed
WO-2010038803-A1 2-INDOLEACRYLAMIDE ANALOGUE 持田製薬株式会社 (JP) 2010-04-08 WO disclosed
WO-2010010934-A1 HETEROCYCLIDENE DERIVATIVE HAVING P-SUBSTITUTED ARYLACETAMIDE 持田製薬株式会社 (JP) 2010-01-28 WO disclosed
US-7354925-B2 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonists PFIZER INC. (US) 2008-04-08 US disclosed
US-20070197500-A1 3-(2,3-Dihydro-1'H-spiro[indene-1,4'-piperidin]-1'-yl)-N,N-dimethyl-2-(pyridin-2-ylmethyl)propanamide; opioid receptor-like 1 antagonist; reduced inhibitory activity at HERG potassium channel; analgesic; side effect reduction; neurpathic and other pain PFIZER, INC. 2007-08-23 US disclosed
EP-1732893-A2 ALPHA ARYL OR HETEROARYL METHYL BETA PIPERIDINO PROPANAMIDE COMPOUNDS AS ORL1-RECEPTOR ANTAGONIST Pfizer Japan, Inc. (JP) 2006-12-20 EP disclosed
WO-2005092858-A2 ALPHA ARYL OR HETEROARYL METHYL BETA PIPERIDINO PROPANAMIDE COMPOUNDS AS ORL1-RECEPTOR ANTAGONIST PFIZER JAPAN INC. (JP) 2005-10-06 WO disclosed